Ronen Ben Jehuda is a senior scientist at Hemogenyx Pharmaceuticals. Ronen has previously worked as a researcher at Technion - Israel Institute of Technology, University of Michigan, and Servier. Ronen has also been a PhD student at Technion. Ronen's research has focused on MACS-based enrichment of induced pluripotent stem cell-derived cardiomyocytes, isolation and culture of adult mouse cardiomyocytes, evaluation of mechanical stress-induced phenotypes in cardiomyocytes, and drug screening.
Ronen Ben Jehuda has a Bachelor of Science in Biotechnology Engineering from the Technion - Israel Institute of Technology, a Doctor of Philosophy in Stem cells and electrophysiology of cardiac muscle from the Technion - Israel Institute of Technology, and a Master of Science in Biotechnology from the Technion - Israel Institute of Technology.
Ronen Ben Jehuda works with Elina Shrestha - Senior Scientist, Cristine Chisholm - Scientist, and Carina Sirochinsky - Associate Scientist. Ronen Ben Jehuda reports to Vladislav Sandler, CEO & Co-Founder.
Current role